Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer.

Dupasquier S, Blache P, Picque Lasorsa L, Zhao H, Abraham JD, Haigh JJ, Ychou M, Prévostel C.

Cancers (Basel). 2019 May 18;11(5). pii: E693. doi: 10.3390/cancers11050693.

2.

A Short SOX9 Peptide Mimics SOX9 Tumor Suppressor Activity and Is Sufficient to Inhibit Colon Cancer Cell Growth.

Blache P, Canterel-Thouennon L, Busson M, Verdié P, Subra G, Ychou M, Prévostel C.

Mol Cancer Ther. 2019 Aug;18(8):1386-1395. doi: 10.1158/1535-7163.MCT-18-1149. Epub 2019 May 15.

PMID:
31092563
3.

A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/β-Catenin Pathway.

Grimaldi M, Boulahtouf A, Prévostel C, Thierry A, Balaguer P, Blache P.

Front Pharmacol. 2018 Oct 11;9:1160. doi: 10.3389/fphar.2018.01160. eCollection 2018.

4.

The dose-dependent effect of SOX9 and its incidence in colorectal cancer.

Prévostel C, Blache P.

Eur J Cancer. 2017 Nov;86:150-157. doi: 10.1016/j.ejca.2017.08.037. Epub 2017 Oct 6. Review.

PMID:
28988015
5.

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.

Prévostel C, Rammah-Bouazza C, Trauchessec H, Canterel-Thouennon L, Busson M, Ychou M, Blache P.

Oncotarget. 2016 Dec 13;7(50):82228-82243. doi: 10.18632/oncotarget.10573.

6.

Protein kinase C(alpha) actively downregulates through caveolae-dependent traffic to an endosomal compartment.

Prevostel C, Alice V, Joubert D, Parker PJ.

J Cell Sci. 2000 Jul;113 ( Pt 14):2575-84.

7.

Membrane targeting and cytoplasmic sequestration in the spatiotemporal localization of human protein kinase C alpha.

Vallentin A, Prévostel C, Fauquier T, Bonnefont X, Joubert D.

J Biol Chem. 2000 Feb 25;275(8):6014-21.

8.

Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes.

Hansra G, Garcia-Paramio P, Prevostel C, Whelan RD, Bornancin F, Parker PJ.

Biochem J. 1999 Sep 1;342 ( Pt 2):337-44.

9.

Imaging protein kinase Calpha activation in cells.

Ng T, Squire A, Hansra G, Bornancin F, Prevostel C, Hanby A, Harris W, Barnes D, Schmidt S, Mellor H, Bastiaens PI, Parker PJ.

Science. 1999 Mar 26;283(5410):2085-9.

10.

Selective loss of substrate recognition induced by the tumour-associated D294G point mutation in protein kinase Calpha.

Prévostel C, Alvaro V, Vallentin A, Martin A, Jaken S, Joubert D.

Biochem J. 1998 Sep 1;334 ( Pt 2):393-7.

11.
12.
13.

Protein kinase C alpha and tumorigenesis of the endocrine gland.

Prévostel C, Martin A, Alvaro V, Jaffiol C, Joubert D.

Horm Res. 1997;47(4-6):140-4.

PMID:
9167945
14.

The natural protein kinase C alpha mutant is present in human thyroid neoplasms.

Prévostel C, Alvaro V, de Boisvilliers F, Martin A, Jaffiol C, Joubert D.

Oncogene. 1995 Aug 17;11(4):669-74.

PMID:
7651730

Supplemental Content

Loading ...
Support Center